Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-29

FDA Approved: VIGABATRIN — Original Application (Dr. Reddys Laboratories Inc.,)

View source ↗

Summary

FDA approves Dr. Reddy's Laboratories' original ANDA for vigabatrin, the generic form of this anticonvulsant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN (VIGABATRIN)